Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

GSK 1,464.50 -5.00 (-0.34%)
price chart
Is It Time To Buy GlaxoSmithKline plc?
While the point I discussed above, coupled with the restructuring that's going on at Glaxo, makes the company look cheap at current levels, you can't afford to base your portfolio solely on the company.
Could You Double Your Money With GlaxoSmithKline plc?
GSK's share price rise represents a compound annual growth rate (CAGR) of 3.3%. Earnings per share (EPS) have increased at a CAGR of just 1.4%, with the remainder of the share price rise coming from an increase in the price-to-earnings (P/E) ratio.
Forget About 2015: Why GlaxoSmithKline plc Should Enjoy Stunning Long-Term ...
Like the rest of the pharmaceuticals sector, GlaxoSmithKline has seen sales of key drugs fall through the floor in recent years, as the entry of generic rivals has eaten away at group sales in established markets.
GlaxoSmithKline plc Receives Hold Rating from Deutsche Bank (GSK)  sleekmoney
GlaxoSmithKline plc Coverage Initiated at BNP Paribas (GSK)  Watch List News (press release)
Related articles »  
Recovering GlaxoSmithKline plc Won't Be Cheap For Much Longer
Pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is one of those rock-solid stocks that you despair of being able to pick up at a bargain price.
GLAXOSMITHKLINE (NYSE:GSK) Ebola vaccine to be ready by end of year  WallStreet Scope
GlaxoSmithKline net earnings dips by 62% in Q3
Related articles »  
Will GlaxoSmithKline plc Be Back To Growth By 2016?
Investing in steadily-growing companies like GlaxoSmithKline has made it possible for many an investor to achieve millionaire status -- and you can do it too.
GlaxoSmithKline plc Is Best In Class When It Comes To Affordable Medicine
Moreover, Glaxo is rapidly closing in on producing the world's first malaria vaccine, after filing for regulatory approval in July.
Related articles »  
Why Forecasts Are Falling At GlaxoSmithKline plc
The company's quarterly figures this year have been falling short of expectations too, and at the first-half stage Glaxo reported a 12% fall in core EPS at constant exchange rates, with the statutory reported figure down 14% - at real exchange rates ...
Why GlaxoSmithKline plc And HSBC Holdings plc Can Be The FTSE 100′s ...
Shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and HSBC (LSE: HSBA) (NYSE: HSBC.US) have delivered disappointing returns during the course of 2014.
Related articles »  
GlaxoSmithKline plc Earns Market Perform Rating from Sanford C. Bernstein (GSK)
Sanford C. Bernstein reaffirmed their market perform rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Tuesday.
BNP Paribas Begins Coverage on GlaxoSmithKline plc (GSK)  Ticker Report
GlaxoSmithKline plc Rating Reiterated by Deutsche Bank (GSK)  The Legacy
Related articles »  
My Top 3 Pharmaceutical Stocks For 2015: GlaxoSmithKline plc, AstraZeneca ...
Investing in BTG, AstraZeneca and GlaxoSmithKline could prove to be a great move for 2015, and I think that all three companies could post excellent returns over the next year.